رجوع
نطاق اليوم
KWD 10.91
KWD 13.51
نطاق 52 أسبوعًا
KWD 10.91
KWD 25.67
حجم التداول
22,707,848
متوسط 50 يوم / 200 يوم
KWD 16.39
/
KWD 17.09
الإغلاق السابق
KWD 13.59
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 18.4 | 0.3 |
| P/B | 5.7 | 2.9 |
| ROE % | 35.6 | 3.7 |
| Net Margin % | 28.8 | 3.8 |
| Rev Growth 5Y % | 58.5 | 10.0 |
| D/E | 0.2 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 16.000
+41.2%
Low: KWD 14.000
High: KWD 18.000
مكرر الربحية المستقبلي
14.2
ربحية السهم المستقبلية
KWD 0.955
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
640 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 2.295
KWD 2.290 – KWD 2.300
|
1.3 B | 1 |
| FY2029 |
KWD 2.005
KWD 2.000 – KWD 2.010
|
1.1 B | 1 |
| FY2028 |
KWD 1.615
KWD 1.520 – KWD 1.710
|
940 M | 2 |
النقاط الرئيسية
Revenue grew 58.45% annually over 5 years — strong growth
Earnings declined -25.67% over the past year
ROE of 35.56% indicates high profitability
Net margin of 28.80% shows strong profitability
Debt/Equity of 0.17 — conservative balance sheet
Generating 27.82M in free cash flow
النمو
Revenue Growth (5Y)
58.45%
Revenue (1Y)19.63%
Earnings (1Y)-25.67%
FCF Growth (3Y)169.91%
الجودة
Return on Equity
35.56%
ROIC25.77%
Net Margin28.80%
Op. Margin37.53%
الأمان
Debt / Equity
0.17
Current Ratio6.71
Interest Coverage26.93
التقييم
P/E Ratio
18.36
P/B Ratio5.65
EV/EBITDA14.05
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.63% | Revenue Growth (3Y) | 40.56% |
| Earnings Growth (1Y) | -25.67% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 58.45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 510.17M | Net Income (TTM) | 146.93M |
| ROE | 35.56% | ROA | 23.54% |
| Gross Margin | 57.39% | Operating Margin | 37.53% |
| Net Margin | 28.80% | Free Cash Flow (TTM) | 27.82M |
| ROIC | 25.77% | FCF Growth (3Y) | 169.91% |
| Safety | |||
| Debt / Equity | 0.17 | Current Ratio | 6.71 |
| Interest Coverage | 26.93 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 18.36 | P/B Ratio | 5.65 |
| P/S Ratio | 5.29 | PEG Ratio | -1.09 |
| EV/EBITDA | 14.05 | Dividend Yield | 0.00% |
| Market Cap | 2.70B | Enterprise Value | 2.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 510.17M | 426.45M | 258.22M | 154.08M | 80.94M |
| Net Income | 146.93M | 197.67M | -28.24M | -65.90M | -71.65M |
| EPS (Diluted) | 0.60 | 0.81 | -0.13 | -0.43 | -0.61 |
| Gross Profit | 292.77M | 219.55M | 88.94M | 35.27M | 1.17M |
| Operating Income | 191.44M | 138.98M | 21.63M | -39.37M | -58.37M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 624.24M | 488.68M | 329.18M | 348.46M | 276.25M |
| Total Liabilities | 146.92M | 139.66M | 193.98M | 196.49M | 135.08M |
| Shareholders' Equity | 477.32M | 349.02M | 135.21M | 151.97M | 141.17M |
| Total Debt | 79.89M | 82.12M | 141.42M | 154.44M | 102.92M |
| Cash & Equivalents | 87.63M | 103.15M | 51.35M | 86.52M | 51.09M |
| Current Assets | 466.51M | 331.41M | 257.01M | 270.40M | 208.73M |
| Current Liabilities | 69.54M | 55.54M | 49.81M | 39.27M | 30.38M |